Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: A PRISMA-compliant Bayesian network meta-analysis.

<h4>Objective</h4>To search, review, and analyze the efficacy and safety of various anticoagulants from randomized clinical trials (RCTs) of anticoagulants for THA and TKA.<h4>Design</h4>PRISMA-compliant Bayesian Network Meta-analysis.<h4>Data sources and study selectio...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tailai He, Fei Han, Jiahao Wang, Yihe Hu, Jianxi Zhu
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/b109ba8aa6d24c1f8b75c0ab40a067f5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b109ba8aa6d24c1f8b75c0ab40a067f5
record_format	dspace
spelling	oai:doaj.org-article:b109ba8aa6d24c1f8b75c0ab40a067f52021-11-25T06:23:32ZEfficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: A PRISMA-compliant Bayesian network meta-analysis.1932-620310.1371/journal.pone.0250096https://doaj.org/article/b109ba8aa6d24c1f8b75c0ab40a067f52021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0250096https://doaj.org/toc/1932-6203<h4>Objective</h4>To search, review, and analyze the efficacy and safety of various anticoagulants from randomized clinical trials (RCTs) of anticoagulants for THA and TKA.<h4>Design</h4>PRISMA-compliant Bayesian Network Meta-analysis.<h4>Data sources and study selection</h4>The databases of The Medline, Embase, ClinicalTrial, and Cochrane Library databases were searched until March 2017 for RCTs of patients undergoing a THA or TKA.<h4>Main outcomes and measures</h4>The primary efficacy measurement was the venous thromboembolism Odds ratio (OR). The safety measurement was the odds ratio of major or clinically relevant bleeding. OR with 95% credibility intervals (95%CrIs) were calculated. Findings were interpreted as associations when the 95%CrIs excluded the null value.<h4>Results</h4>Thirty-five RCTs (53787 patients; mean age range, mostly 55-70 years; mean weight range, mostly 55-90 kg; and a higher mean proportion of women than men, around 60%) included the following Anticoagulants categories: fondaparinux, edoxaban, rivaroxaban, apixaban, dabigatran, low-molecular-weight heparin, ximelagatran, aspirin, warfarin. Anticoagulants were ranked for effectiveness as follows: fondaparinux (88.89% ± 10.90%), edoxaban (85.87% ± 13.34%), rivaroxaban (86.08% ± 10.23%), apixaban (68.26% ± 10.82%), dabigatran (41.63% ± 12.26%), low-molecular-weight heparin (41.03% ± 9.60%), ximelagatran (37.81% ± 15.87%), aspirin (35.62% ± 20.60%), warfarin (9.89% ± 9.07%), and placebo (4.56% ± 6.37%). Ranking based on clinically relevant bleeding events was as follows: fondaparinux (14.53% ± 15.25%), ximelagatran (18.93% ± 17.49%), rivaroxaban (23.86% ± 15.14%), dabigatran (28.30% ± 14.18%), edoxaban (38.76% ± 24.25%), low-molecular-weight heparin (53.28% ± 8.40%), apixaban (71.81% ± 10.92%), placebo (76.26% ± 14.61%), aspirin (86.32% ± 25.74%), and warfarin (87.95% ± 11.27%). No statistically significant heterogeneity was observed between trials.<h4>Conclusions and relevance</h4>According to our results, all anticoagulant drugs showed some effectiveness for VTE prophylaxis. Our ranking indicated that fondaparinux and rivaroxaban were safer and more effective than other anticoagulant drugs for patients undergoing THA or TKA.Tailai HeFei HanJiahao WangYihe HuJianxi ZhuPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 6, p e0250096 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Tailai He Fei Han Jiahao Wang Yihe Hu Jianxi Zhu Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: A PRISMA-compliant Bayesian network meta-analysis.
description	<h4>Objective</h4>To search, review, and analyze the efficacy and safety of various anticoagulants from randomized clinical trials (RCTs) of anticoagulants for THA and TKA.<h4>Design</h4>PRISMA-compliant Bayesian Network Meta-analysis.<h4>Data sources and study selection</h4>The databases of The Medline, Embase, ClinicalTrial, and Cochrane Library databases were searched until March 2017 for RCTs of patients undergoing a THA or TKA.<h4>Main outcomes and measures</h4>The primary efficacy measurement was the venous thromboembolism Odds ratio (OR). The safety measurement was the odds ratio of major or clinically relevant bleeding. OR with 95% credibility intervals (95%CrIs) were calculated. Findings were interpreted as associations when the 95%CrIs excluded the null value.<h4>Results</h4>Thirty-five RCTs (53787 patients; mean age range, mostly 55-70 years; mean weight range, mostly 55-90 kg; and a higher mean proportion of women than men, around 60%) included the following Anticoagulants categories: fondaparinux, edoxaban, rivaroxaban, apixaban, dabigatran, low-molecular-weight heparin, ximelagatran, aspirin, warfarin. Anticoagulants were ranked for effectiveness as follows: fondaparinux (88.89% ± 10.90%), edoxaban (85.87% ± 13.34%), rivaroxaban (86.08% ± 10.23%), apixaban (68.26% ± 10.82%), dabigatran (41.63% ± 12.26%), low-molecular-weight heparin (41.03% ± 9.60%), ximelagatran (37.81% ± 15.87%), aspirin (35.62% ± 20.60%), warfarin (9.89% ± 9.07%), and placebo (4.56% ± 6.37%). Ranking based on clinically relevant bleeding events was as follows: fondaparinux (14.53% ± 15.25%), ximelagatran (18.93% ± 17.49%), rivaroxaban (23.86% ± 15.14%), dabigatran (28.30% ± 14.18%), edoxaban (38.76% ± 24.25%), low-molecular-weight heparin (53.28% ± 8.40%), apixaban (71.81% ± 10.92%), placebo (76.26% ± 14.61%), aspirin (86.32% ± 25.74%), and warfarin (87.95% ± 11.27%). No statistically significant heterogeneity was observed between trials.<h4>Conclusions and relevance</h4>According to our results, all anticoagulant drugs showed some effectiveness for VTE prophylaxis. Our ranking indicated that fondaparinux and rivaroxaban were safer and more effective than other anticoagulant drugs for patients undergoing THA or TKA.
format	article
author	Tailai He Fei Han Jiahao Wang Yihe Hu Jianxi Zhu
author_facet	Tailai He Fei Han Jiahao Wang Yihe Hu Jianxi Zhu
author_sort	Tailai He
title	Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: A PRISMA-compliant Bayesian network meta-analysis.
title_short	Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: A PRISMA-compliant Bayesian network meta-analysis.
title_full	Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: A PRISMA-compliant Bayesian network meta-analysis.
title_fullStr	Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: A PRISMA-compliant Bayesian network meta-analysis.
title_full_unstemmed	Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: A PRISMA-compliant Bayesian network meta-analysis.
title_sort	efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: a prisma-compliant bayesian network meta-analysis.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/b109ba8aa6d24c1f8b75c0ab40a067f5
work_keys_str_mv	AT tailaihe efficacyandsafetyofanticoagulantsforpostoperativethrombophylaxisintotalhipandkneearthroplastyaprismacompliantbayesiannetworkmetaanalysis AT feihan efficacyandsafetyofanticoagulantsforpostoperativethrombophylaxisintotalhipandkneearthroplastyaprismacompliantbayesiannetworkmetaanalysis AT jiahaowang efficacyandsafetyofanticoagulantsforpostoperativethrombophylaxisintotalhipandkneearthroplastyaprismacompliantbayesiannetworkmetaanalysis AT yihehu efficacyandsafetyofanticoagulantsforpostoperativethrombophylaxisintotalhipandkneearthroplastyaprismacompliantbayesiannetworkmetaanalysis AT jianxizhu efficacyandsafetyofanticoagulantsforpostoperativethrombophylaxisintotalhipandkneearthroplastyaprismacompliantbayesiannetworkmetaanalysis
_version_	1718413821756833792

Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: A PRISMA-compliant Bayesian network meta-analysis.

Ejemplares similares